Metformin_Hydrochloride: profile and news

American Journal of Clinical Nutrition, Vol. 83, No. 2, 466S-469S ... Feb 9, 2006
Furthermore, metformin hydrochloride, a therapy that improves insulin sensitivity by increasing peripheral glucose uptake and utilization and decreasing ... - Am J Clin Nutr (subscription),

SNDA for a Fast-acting Postprandial Hypoglicemic Agent FASTIC ... Jan 27, 2006
...agents that improve insulin resistance by the main action mechanism of hepatic glucose production inhibition of which metformin hydrochloride and buformin ... - PharmaLive.com (press release),

Stocks Under $10 Weekly Summary Jan 20, 2006
...suit filed last week against Ivax (IVX:Amex), DepoMed is alleging that Ivax's diabetes treatment, extended release metformin hydrochloride, infringes DepoMed's ... - TheStreet.com (subscription),

Preserving Competition, FTC Requires Divestitures Before Allowing ... Jan 23, 2006
...from Teva, to be divested to Par; 12) tramadol/acetaminophen tablets from Teva, to be divested to Barr; 13) glipizide and metformin hydrochloride tablets from ... - PharmaLive.com (press release),

Do the math: Same drugs, lower price Jan 15, 2006
For example, Metformin hydrochloride, a diabetes drug, cost $18 at Johnson compared with $88.19 at Walgreens and $85.59 at CVS at the same quantity and ... - Boston Globe,

Mylan Announces Approval for Metformin Hydrochloride Extended ... Sep 14, 2005
...final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for Metformin Hydrochloride Extended-release ... - PR Newswire (press release),

Impax gets FDA OK for Glucophage version Sep 14, 2005
The company received approval to market 750-milligram strength extended-release tablets of metformin hydrochloride, the active ingredient of Glucophage. ... - BusinessWeek

Mylan Gets FDA OK for Glucophage Version Sep 14, 2005
The approval allows Mylan to sell 500 milligram and 750 milligram extended-release tablets of metformin hydrochloride, the active ingredient of Glucophage ... - Forbes

(PRN) - Dofasco issues third quarter earnings advisory ... [+] Sep 14, 2005
September ... [+. PRN) - Mylan Announces Approval for Metformin Hydrochloride Extended-release Tablets, 500 mg and 750 mg ... [+. ... - Bolsamania.com,

FDA panel OKs Bristol-Myers diabetes drug Sep 9, 2005
The panel also recommended that Pargluva be used alone or in combination with Bristol-Myers' Glucophage, also known as metformin hydrochloride. ... - MarketWatch

FDA panel OKs Bristol-Myers diabetes drug Sep 9, 2005
The panel also recommended that Pargluva be used alone or in combination with Bristol-Myers' (BMY) Glucophage, also known as metformin hydrochloride. ... - Investor's Business Daily (subscription)

Aurobindo to sell Metformin Hydrochloride in Europe Jul 6, 2005
...of Suitability from the European Directorate for the Quality of Medicines (EDQM) for its Active Pharmaceutical Ingredient (API) Metformin Hydrochloride. ... - Hindu

Aurobindo Pharma gets approval for Metformin Hydrochloride to sell ... Jul 6, 2005
European Pharmacopoeia by the European Directorate for the Quality of Medicines (EDQM) for its Active pharmaceutical ingredient (API) Metformin Hydrochloride. ... - Myiris.com

Biovail Reports Second-Quarter 2005 Financial Results Aug 4, 2005
Biovail received US Food & Drug Administration (FDA) approval for Glumetza(TM) (a once-daily, extended-release formulation of metformin hydrochloride for the ... - Business Wire (press release)

Ranbaxy Gains Approval To Market Metformin XL Tablets, 750 mg Jul 7, 2005
...announced today that RLL has received approval from the US Food and Drug Administration to manufacture and market Metformin Hydrochloride Extended- release ... - Webnewswire.com

Depomed, Esprit Enter $50M Deal To Market Proquin XR Jul 28, 2005
In June, the FDA approved Glumetza, Depomed's once-daily, extended-release formulation of metformin hydrochloride to treat Type II diabetes, partnered with ... - BioWorld Online (subscription)

Aurobindo Pharma gets access to European markets Jul 7, 2005
With this approval, the company will have the license to sell its active pharmaceutical ingredient (API) Metformin Hydrochloride in entire Europe without any ... - NewKerala.com

Ranbaxy gets USFDA approval for metformin tabs Jul 8, 2005
...announced that the company has received approval from the US Food and Drug Administration to manufacture and market metformin hydrochloride extended-release ... - Express Pharma Pulse

Market Mood: This Morning Jul 7, 2005
...of the European Pharmacopoeia by the European Directorate for the Quality of Medicines for its active pharmaceutical ingredient, Metformin Hydrochloride. ... - Sify <**results**>

Ranbaxy Gains Approval To Market Metformin XL Tablets, 750 mg Jul 5, 2005
...announced today that RLL has received approval from the US Food and Drug Administration to manufacture and market Metformin Hydrochloride Extended- release ... - Yahoo News (press release)

Ranbaxy Laboratories gets US FDA nod for Metformin XL Tablets, 750 ... Jul 4, 2005
Ranbaxy Laboratories Ltd has received approval from the US Food & Drug Administration to manufacture and market Metformin Hydrochloride Extended-release Tablets ... - Myiris.com

Ranbaxy gets USFDA nod for Metformin tablets Jul 4, 2005
Ranbaxy Laboratories has received approval from the USFDA to manufacture and market anti-diabetic drug Metformin Hydrochloride (Extended-Release) tablets of ... - Business Standard

Ranbaxy gets US FDA approval for Metformin XL Tablets, 750 mg Jul 4, 2005
Laboratories Ltd today said it has received approval from the USFDA to manufacture and market anti-diabetic drug Metformin Hydrochloride extended-release ... - Press Trust of India

Ranbaxy gets US nod to sell diabetes medicines Jul 4, 2005
With the approval, Ranbaxy will be able to manufacture and market Metformin Hydrochloride tablets in the US, said a company statement issued here. ... - NewKerala.com

RLL gets FDA nod for anti-diabetic drug Jul 4, 2005
100th abbreviated new drug approval (ANDA) from the US Food and Drug Administration (FDA) for its anti-diabetic drug, Metformin Hydrochloride extended-release ... - Sify

Ranbaxy gets USFDA nod to market anti-diabetic drug Jul 4, 2005
...on Monday announced that, it has received approval from the US Food & Drug Administration to manufacture and market Metformin Hydrochloride Extended-release ... - India Infoline.com

Gujarat NRE Coke acquires mine in Australia(CORPORATE CAPSULE):- Jul 4, 2005
With the approval, Ranbaxy will be able to manufacture and market Metformin Hydrochloride tablets in the US, said a company statement issued here. ... - Webindia123

US drug authority okays Ranbaxy's anti-diabetic drug Jul 4, 2005
Ltd on Monday said that it has received approval from the USFDA to manufacture and market anti-diabetic drug Metformin hydrochloride extended-release tablets ... - Hindu Business Line

Bourses close at record highs Jul 4, 2005
Ranbaxy Labs has received approval from the US Food & Drug Administration (USFDA) to manufacture and market 750 mg metformin hydrochloride extended-release ... - Financial Express

GlaxoSmithKline announces availability of Paxil CR to US market Jun 27, 2005
With respect to Avandamet (rosiglitazone maleate/metformin hydrochloride) tablets, the Company anticipates resupplying the distribution channels within two ... - News-Medical.net

Wanbury Ltd (Originally Pearl Organics) Jun 28, 2005
Pearl Organics is a leading bulk manufacturer of anti-diabetes bulk active, metformin hydrochloride, and anti-inflammatory and analgesic salsalate. ... - India Infoline.com,

GlaxoSmithKline announces availability of Paxil CR to US market 13 Sep 2002
With respect to Avandamet (rosiglitazone maleate/metformin hydrochloride) tablets, the Company anticipates resupplying the distribution channels within two ... - News-Medical.net,

Biovail, Depomed Announce Regulatory Approval of Glumetza to Treat ... Jun 1, 2005
TPD) has issued a Notice of Compliance for 500mg and 1,000mg Glumetza(TM), a once-daily, extended-release formulation of metformin hydrochloride (HCl) for the ... - RedNova.com,

FDA Approves Extended-release Formulations of Metformin Jun 3, 2005
...from the United States Food and Drug Administration (FDA) for Glumetza(TM), a once-daily, extended-release formulation of metformin hydrochloride (HCl) for the ... - RxPG NEWS,

Biovail says diabetes drug Glumetza has key approval in Canada ... Jun 1, 2005
The Therapeutic Products Directorate Canada has approved two dosage strengths of the drug, a once-daily formulation of metformin hydrochloride for treating ... - National Post,

Depomed, Biovail Get Glumetza FDA OK Jun 3, 2005
...adult-onset diabetes. Glumetza is a once-a-day, extended-release formulation of diabetes treatment metformin hydrochloride. The FDA ... - MSN Money